Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Kivu Bioscience Inc.
MacroGenics
Boundless Bio, Inc.
Novelty Nobility, Inc.
Xencor, Inc.
Celgene
Pfizer
Merrimack Pharmaceuticals
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Virginia Commonwealth University
National Cancer Institute (NCI)
Dartmouth-Hitchcock Medical Center
Memorial Sloan Kettering Cancer Center
Novartis
Alaunos Therapeutics
National Institutes of Health Clinical Center (CC)
Astellas Pharma Inc
NYU Langone Health
Case Comprehensive Cancer Center